enocitabine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| nucleosides antiviral or antineoplastic agents, cytarabine or azacitidine derivatives | 1012 | 55726-47-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| FDA MoA | N0000000233 | Nucleic Acid Synthesis Inhibitors |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000970 | Antineoplastic Agents |
| MeSH PA | D000998 | Antiviral Agents |
| MeSH PA | D000963 | Antimetabolites |
| MeSH PA | D000964 | Antimetabolites, Antineoplastic |
| MeSH PA | D007155 | Immunologic Factors |
| MeSH PA | D007166 | Immunosuppressive Agents |
| MeSH PA | D009676 | Noxae |
| FDA EPC | N0000175595 | Nucleoside Metabolic Inhibitor |
| CHEBI has role | CHEBI:22587 | antiviral agents |
| CHEBI has role | CHEBI:35221 | antimetabolite |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| CHEBI has role | CHEBI:35705 | immunosuppressive agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 11.91 | acidic |
| pKa2 | 12.42 | acidic |
| pKa3 | 12.58 | acidic |
| pKa4 | 13.11 | acidic |
| pKa5 | 1.62 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D01633 | KEGG_DRUG |
| 4018080 | VANDF |
| C0059364 | UMLSCUI |
| CHEBI:31537 | CHEBI |
| CHEBI:28680 | CHEBI |
| AR3 | PDB_CHEM_ID |
| CHEMBL2106589 | ChEMBL_ID |
| C015019 | MESH_SUPPLEMENTAL_RECORD_UI |
| 5121 | INN_ID |
| 9YVR68W306 | UNII |
| 71734 | PUBCHEM_CID |
| 3041 | RXNORM |
| 372 | MMSL |
| 4526 | MMSL |
| d00201 | MMSL |
| 002649 | NDDF |
| 010917 | NDDF |
| 387511003 | SNOMEDCT_US |
| 89265009 | SNOMEDCT_US |
| C0010711 | UMLSCUI |
| DB00987 | DRUGBANK_ID |
| 1709 | INN_ID |
| D003561 | MESH_DESCRIPTOR_UI |
| 6253 | PUBCHEM_CID |
Pharmaceutical products:
None